The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...
A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...
Some hereditary genetic defects cause an exaggerated immune response that can be fatal. Using the CRISPR-Cas9 gene-editing tool, such defects can be corrected, thus normalizing the immune response, as ...
The possibility of editing our genes once seemed more like science fiction than reality. Times have changed with the development of CRISPR-Cas9, a gene-editing tool first used in 2012. Gene editing is ...
Waking up this morning to news of the much-deserved Nobel Prize win for Emmanuelle Charpentier and Jennifer A. Doudna "for the development of a method for genome editing" confirms the importance of ...
The immune system plays a crucial role in fighting tumors and metastases. Consequently, it is decisive to conduct cancer ...
JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...
In the present study, we investigated whether electroporation could be used for one-step multiplex CRISPR/Cas9-based genome editing, targeting IL2RG and GHR in porcine embryos. First, we evaluated and ...
U.S. patent granted for CRISPR-Cas9 RNP platform technology in the world's largest biotech market - Next-generation platform that enhances editing efficiency and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback